ConductScience.org, home

Paper39759554

Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.

Najjar F and 7 others. Rep Pract Oncol Radiother, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer. Papers, record 39759554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39759554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.
PubMed
Journal
Rep Pract Oncol Radiother
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.5, provisional
iCite
Revised in PubMed
2025-01-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Najjar FFadihttps://orcid.org/0000-0002-6169-1576
2Alsabe HHassan
3Sabbagh HHussein
4Al-Massarani GGhassan
5Aljapawe AAbdulmunim
6Alamalla NNissreen
7Banat IIssraa
8Ikhtiar AAdnan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128456778Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients.J Physiol Pharmacol2017https://conductscience.org/library/papers/28456778PubMed
212654259Angiogenesis and apoptosis.Semin Cancer Biol2003https://conductscience.org/library/papers/12654259PubMed
337456701Locally advanced non-small cell lung cancer: current issues and recent trends.Rep Pract Oncol Radiother2023https://conductscience.org/library/papers/37456701PubMed
423882070Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival.Eur J Cardiothorac Surg2013https://conductscience.org/library/papers/23882070PubMed
516550195The hematopoietic stem cell in its place.Nat Immunol2006https://conductscience.org/library/papers/16550195PubMed
621927909Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer.J Cancer Res Clin Oncol2011https://conductscience.org/library/papers/21927909PubMed
716849585Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.Cancer Res2006https://conductscience.org/library/papers/16849585PubMed
829391882Roles of circulating endothelial progenitor cells and endothelial cells in gastric carcinoma.Oncol Lett2018https://conductscience.org/library/papers/29391882PubMed
922198428
Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
J Thorac Oncol2012https://conductscience.org/library/papers/22198428PubMed
1029872695The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients.NPJ Precis Oncol2017https://conductscience.org/library/papers/29872695PubMed
1112837583Endothelial progenitor cells: isolation and characterization.Trends Cardiovasc Med2003https://conductscience.org/library/papers/12837583PubMed
1222160642Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22160642PubMed
1328982871Association Between Endothelial Progenitor Cells and Treatment Response in Non-Squamous Non-small Cell Lung Cancer Treated with Bevacizumab.Anticancer Res2017https://conductscience.org/library/papers/28982871PubMed
1418443294Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18443294PubMed
1519097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1620732306Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis.Biochem Biophys Res Commun2010https://conductscience.org/library/papers/20732306PubMed
1726917455Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.Crit Rev Oncol Hematol2016https://conductscience.org/library/papers/26917455PubMed
1814528288Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.Oncogene2003https://conductscience.org/library/papers/14528288PubMed
1916549839
Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
J Clin Oncol2006https://conductscience.org/library/papers/16549839PubMed
2031731627Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence.J Clin Med2019https://conductscience.org/library/papers/31731627PubMed

See all 47 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42015273The predictive value and clinical application of measuring circulating endothelial progenitor cells in lung adenocarcinoma.J Cardiothorac Surg2026https://conductscience.org/library/papers/42015273PubMed
41498077The evaluation of serum magnesium and calcium/magnesium ratio in patients with breast cancer receiving adjuvant chemotherapy.Rep Pract Oncol Radiother2025https://conductscience.org/library/papers/41498077PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
MCAM4162PubTator's text mininghttps://conductscience.org/library/genes/4162NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39759554

GET https://conductscience.org/api/papers/v1/39759554/references?page=2